Utilizing Carbon Dioxide for Assessing Coronary Blood Flow in Subjects With Coronary Artery Disease

Part of paid clinical trials in Indianapolis, Indiana.

Sponsor
Indiana University
Study ID
NCT06253884
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Coronary Artery Disease

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • RespirAct — DEVICE
    RespirAct device-based computer-controlled gas delivery at different concentrations as per protocol

Study Details

This is a prospective pilot study to evaluate the safety, tolerability and technical feasibility of utilizing carbon dioxide for assessing coronary blood flow in subjects with coronary artery disease.

Key Dates

Start date
Jan 10, 2027
Status verified
May 2026
Primary completion
Nov 15, 2027
Completion
Dec 15, 2027

Study Design

Enrollment
30 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: Coronary Artery Disease (CAD) Subjects
    Subjects with a of coronary artery disease will undergo computer-controlled gas challenges.

Primary Outcome Measure

Ratio of Maximum Signal Intensity (MSI) by BOLD MRI [ Time Frame: 3 hours ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
IU Health Methodist HospitalIndianapolisIndiana46202
Rohan Dharmakumar, PhD
[email protected]
317-274-0992
Keyur Vora, MD MS (SUB_INVESTIGATOR)

Find similar trials in Indianapolis, IN

By research site
IU Health Methodist Hospital· Indianapolis, IN

Related Studies